This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $300 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoLive In-Person Event: December 4 - 8, 2022

Jonathan Davis, Ph.D.
Vice President of Innovation and Strategy at Invenra, Inc.


Jonathan Davis is Vice President of Innovation and Strategy at Invenra, where he brings over 20 years of experience in industry, focused on innovative protein and antibody engineering, bispecific and multispecific antibody platform development, and drug discovery in a wide range of therapeutic areas. Prior to joining Invenra, Dr. Davis has held positions at Bristol-Myers Squibb, where he worked on all aspects of biologic drug design, including successfully designing a trispecific HIV biotherapeutic, and EMD Serono, where he developed novel biologic drug platforms. Prior to his industry jobs, Dr. Davis was a post-doctoral fellow at Harvard Medical School, and earned a Ph.D. in Biophysics from Univ. of Cal. San Francisco and a bachelor’s degrees in music and cello from Reed College and San Francisco Conservatory of Music.

Jonathan Davis, Ph.D.'s Network

Agenda Sessions

  • Bispecific SNIPER B-Body Effectively Targets Tumor-resident Tregs